Page 151 - Vitamin D and Cancer

138 R. Scragg

118. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997)
Active serum vitamin D levels are inversely correlated with coronary calcification.
Circulation 96:1755–1760
119. Doherty TM, Tang W, Dascalos S, Watson KE, Demer LL, Shavelle RM, Detrano RC (1997)
Ethnic origin and serum levels of 1alpha, 25-dihydroxyvitamin D3 are independent predic-
tors of coronary calcium mass measured by electron-beam computed tomography.
Circulation 96:1477–1481
120. Arad Y, Spadaro LA, Roth M, Scordo J, Goodman K, Sherman S, Lerner G, Newstein D,
Guerci AD (1998) Serum concentration of calcium, 1, 25 vitamin D and parathyroid hor-
mone are not correlated with coronary calcifications. An electron beam computed tomogra-
phy study. Coron Artery Dis 9:513–518
121. Bonjour JP, Chevalley T, Fardellone P (2007) Calcium intake and vitamin D metabolism and
action, in healthy conditions and in prostate cancer. Br J Nutr 97:611–616
122. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients
undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446–456
123. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S,
Ishimura E, Miki T et al (2004) Lower risk for cardiovascular mortality in oral 1alpha-
hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant
19:179–184
124. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R
(2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
J Am Soc Nephrol 16:1115–1125
125. Naves-Diaz M, Alvarez-Hernandez D, Passlick-Deetjen J, Guinsburg A, Marelli C,
Rodriguez-Puyol D, Cannata-Andia JB (2008) Oral active vitamin D is associated with
improved survival in hemodialysis patients. Kidney Int 74:1070–1078
126. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR
(2006) Changes in serum calcium, phosphate, and PTH and the risk of death in incident
dialysis patients: a longitudinal study. Kidney Int 70:351–357
127. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS,
McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying
indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780
128. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK,
Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D
analogs. Kidney Int 70:1858–1865
129. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Association of acti-
vated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med
168:397–403
130. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B (2008) Association of oral
calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19:1613–1619
131. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo
CA Jr, Tonelli M et al (2007) Vitamin D levels and early mortality among incident hemodi-
alysis patients. Kidney Int 72:1004–1013
132. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr,
Melamed M, Norris K et al (2008) Impact of activated vitamin D and race on survival among
hemodialysis patients. J Am Soc Nephrol 19(7):1379–1388
133. Al-Aly Z (2007) Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis
patients: the need for randomized trials. Kidney Int 72:909–911
134. de Boer IH, Kestenbaum B (2008) Vitamin D in chronic kidney disease: is the jury in?
Kidney Int 74:985–987
135. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ,
D’Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular
disease. Circulation 117:503–511
136. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-hydroxyvitamin D and risk of myo-
cardial infarction in men: a prospective study. Arch Intern Med 168:1174–1180